UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 8, 2008
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware |
1-3433 |
38-1285128 |
2030 Dow Center, Midland, Michigan 48674
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(989) 636-1000
Not applicable
(Former name or former address, if changed since last report.)
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
(a) On October 8, 2008, the Board of Directors of The Dow Chemical Company (the "Company") amended Sections 3.9, 4.1, 4.4 and 5.19 of the Company's Bylaws, effective as of October 9, 2008, to provide for a Board Committee name change.
Item 9.01 Financial Statements and Exhibits
The following exhibit is filed as part of this report:
EXHIBIT NO. DESCRIPTION
as amended and re-adopted in full,
effective on October 9, 2008.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: October 13, 2008
THE DOW CHEMICAL COMPANY
By: /s/ William H. Weideman
Name: William H. Weideman
Title: Vice President and
Controller